Back to TWO SIGMA INVESTMENTS, LP TWO SIGMA INVESTMENTS, LP

CLDXCLDX
23 quarters

Position history for TWO SIGMA INVESTMENTS, LPTWO SIGMA INVESTMENTS, LP's holdings in Celldex Therapeutics, Inc.

TWO SIGMA INVESTMENTS, LP holds 661,235 shares of CLDX (Celldex Therapeutics, Inc.), worth $24.6M as of 2026-Q2. The position was increased (+382.6% shares). CLDX represents 0.0% of TWO SIGMA INVESTMENTS, LP's portfolio.

Current Value

$24.6M

Current Shares

661,235

Total Value Change

+$24.5M

Total Shares Change

+626,927

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
661,235
+382.6%
$24.6M0.0%$37.21
46
2026-Q1
Increased
137,015
+3.4%
$4.3M0.0%$28.94
28
2025-Q4
Increased
132,533
+80.6%
$3.6M0.0%$26.43
41
2025-Q3
Decreased
73,401
-9.1%
$1.9M0.0%$26.19
0
2025-Q2
Increased
80,733
+181.7%
$1.6M0.0%$20.29
41
2025-Q1
Decreased
28,656
-13.2%
$520,1060.0%$19.93
0
2024-Q4
New
33,025
-
$834,5420.0%$25.12
34
2024-Q2
Exited
0
-100.0%
$00.0%$37.01
0
2024-Q1
New
151,391
-
$6.4M0.0%$41.97
38
2023-Q3
Exited
0
-100.0%
$00.0%$27.52
0
2023-Q2
Decreased
18,423
-26.6%
$625,0920.0%$34.58
0
2023-Q1
New
25,084
-
$902,5220.0%$35.58
34
2022-Q4
Exited
0
-100.0%
$00.0%$44.57
0
2022-Q3
Decreased
29,780
-89.1%
$837,0000.0%$28.35
0
2022-Q2
Increased
273,620
+19.5%
$7.4M0.0%$27.83
32
2022-Q1
Increased
228,948
+18.2%
$7.8M0.0%$34.59
32
2021-Q4
New
193,641
-
$7.5M0.0%$38.90
38
2021-Q1
Exited
0
-100.0%
$00.0%$19.73
0
2020-Q4
Decreased
196,792
-49.5%
$3.4M0.0%$17.88
0
2020-Q3
Increased
389,942
+197.4%
$5.8M0.0%$15.19
44
2020-Q2
New
131,094
-
$1.7M0.0%$12.48
36
2019-Q3
Exited
0
-100.0%
$00.0%$2.17
0
2019-Q2
New
34,308
-
$92,0000.0%$2.68
30

Other major holders of CLDX: BNP PARIBAS FINANCIAL MARKETS, WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used